pulseadmin
170 Views
In a recent update, Acadia Pharmaceuticals announced that Nuplazid, along with its other brand Daybue, is projected to generate more than $1 billion in net sales in 2025.
“The growing success of Nuplazid in the US underscores the global demand for this innovative therapy, and we are confident…
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%
AcceptHere you'll find all collections you've created before.
GIPHY App Key not set. Please check settings